Appili Therapeutics Inc Class A (TSE:APLI) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Appili Therapeutics has received the final court approval for its acquisition by Aditxt, Inc., marking a significant milestone in the transaction process. This move will eventually lead to Appili’s delisting from the Toronto Stock Exchange. The transaction is expected to close by the end of 2024, subject to remaining conditions.
For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.
